Holmium laser enucleation in the surgical treatment of prostate adenoma in the Kyrgyz Republic

This article evaluates the effectiveness and safety of the Holmium Laser Enucleation method for the surgical treatment of prostate adenoma in the Kyrgyz Republic. A prospective study conducted between two thousand twenty and two thousand twenty-four included one thousand two hundred eleven patients, categorized into groups based on prostate volume. The study aimed to confirm the method's consistent efficacy regardless of the gland's size. Holmium Laser Enucleation demonstrated high and comparable effectiveness across all patient groups. Post-operative parameters, including the International Prostate Symptom Score and maximum urinary flow rate, showed no statistically significant differences during the twelve-month follow-up period. The average duration of catheterization was twenty-four hours, and hospitalization lasted three days. Temporary stress urinary incontinence was recorded in only three-point six percent of patients. Holmium Laser Enucleation is a safe and effective method for treating prostate adenoma, applicable to glands of any size. Its advantages, such as minimal blood loss, short hospitalization, and the absence of Transurethral Resection syndrome risk, establish it as an endoscopic alternative to open adenomectomy and the new “gold standard”